Absci ABSI
NASDAQ ABSI
$8.82 +0.02 (+0.23%)
As of: Sep 4, 2026 · 3:59 PM EDT

Absci (ABSI) Enterprise Value (2021 - 2026)

Absci (ABSI) posted Enterprise Value of -$125.7 million for Q1 2026, up 12.88% sequentially from -$144.3 million in Q4 2025, and up 6.18% YoY from -$118.4 million in Q1 2025.

Analysis

Absci (ABSI) Enterprise Value (2021 - 2026) Analysis & Trends

Absci has reported Enterprise Value for 7 years, with the latest figure at -$125.7 million in Q1 2026.

  • Quarterly Enterprise Value rose 6.18% year-over-year to -$125.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$125.7 million (up 6.18% YoY) and the FY2025 annual result came in at -$144.3 million, down 28.35% from the prior year.
  • Enterprise Value grew to -$125.7 million in Q1 2026 per ABSI's latest filing, from -$144.3 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$50.0 million in Q2 2022 and troughed at -$226.0 million in Q1 2022.
  • A 5-year average of -$136.6 million and a median of -$134.0 million in 2025 frame the typical range for Enterprise Value.
  • The sharpest annual moves came in 2022 and 2023: Enterprise Value slumped 180.74% in 2022, then jumped 40.61% in 2023.
  • Over 5 years, Enterprise Value stood at -$164.4 million in 2022, then surged by 40.61% to -$97.7 million in 2023, then decreased by 15.12% to -$112.4 million in 2024, then declined by 28.35% to -$144.3 million in 2025, then rose by 12.88% to -$125.7 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods registered -$125.7 million, -$144.3 million, and -$152.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Absci 1.39 Bn 1.19 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.79 Bn
Mar 31, 2026 342.01 Mn
Dec 31, 2025 389.75 Mn
Sep 30, 2025 304.65 Mn
Jun 30, 2025 266.82 Mn
Mar 31, 2025 186.19 Mn
Dec 31, 2024 189.82 Mn
Sep 30, 2024 309.14 Mn
Jun 30, 2024 204.16 Mn
Mar 31, 2024 480.29 Mn
Dec 31, 2023 293.31 Mn
Sep 30, 2023 9.20 Mn
Jun 30, 2023 16.15 Mn
Mar 31, 2023 17.59 Mn
Dec 31, 2022 29.63 Mn
Sep 30, 2022 109.42 Mn
Jun 30, 2022 102.01 Mn
Mar 31, 2022 556.60 Mn
Dec 31, 2021 154.85 Mn
Sep 30, 2021 573.12 Mn